Structural basis for the inhibition of HKU8 main protease by nirmatrelvir and ensitrelvir
Authors:
- Mengmeng LinMLMengmeng Lin
- Xudong ZengXZXudong Zeng
- Yunjie XiaoYXYunjie Xiao
- Meng ZhangMZMeng Zhang
- Dong LiDLDong Li
- Deping WangDWDeping Wang
- 4 August 2026
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 833
Abstract
No abstract availableFunding Information
- Chongqing Municipal Science and Technology Bureau (CSTB2023NSCQ- BHX0008)
- National Natural Science Foundation of China (32401055)
This publication has 21 references indexed in Scilit:
- A novel, covalent broad-spectrum inhibitor targeting human coronavirus MproNature Communications, 2025
- Assessment and sero-diagnosis for coronaviruses with risk of human spilloverEmerging Microbes & Infections, 2023
- Molecular mechanism of ensitrelvir inhibiting SARS-CoV-2 main protease and its variantsCommunications Biology, 2023
- The coronavirus recombination pathwayCell Host & Microbe, 2023
- Human coronaviruses: Origin, host and receptorJournal of Clinical Virology, 2022
- Nirmatrelvir Plus Ritonavir: First ApprovalDrugs, 2022
- Ranking the risk of animal-to-human spillover for newly discovered virusesProceedings of the National Academy of Sciences, 2021
- The molecular virology of coronavirusesJournal of Biological Chemistry, 2020
- Bat-borne virus diversity, spillover and emergenceNature Reviews Microbiology, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020